Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
NPJ Regenerative Medicine|September 25, 2021
Mitochondrial augmentation of CD34+ cells from healthy donors and patients with mitochondrial DNA disorders confers functional benefitElad Jacoby, Moriya Ben Yakir-Blumkin, Shiri Blumenfeld-Kan, et al.
Journal for Immunotherapy of Cancer|March 11, 2020
Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patientsOrit Itzhaki, Elad Jacoby, Abraham Nissani, et al.
Leukemia & Lymphoma|September 16, 2022
Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucelShalev Fried, Roni Shouval, Nira Varda-Bloom, et al.
American Journal of Hematology|September 7, 2018
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemiaElad Jacoby, Bella Bielorai, Abraham Avigdor, et al.
Pediatric Blood & Cancer|October 14, 2024
Long-term hematopoietic dysfunction in patients with large-scale mitochondrial DNA deletion syndromesNoa Greenberg-Kushnir, Liron D Grossmann, Assaf Arie Barg, et al.
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
Pageof 9